Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
ImmunoFrontier, Inc.
ClinicalTrials.gov Identifier:
NCT01234012
First received: October 26, 2010
Last updated: May 28, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)